| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2025 , Vol 63 , Num 4
Evaluation of serum HMGB-1 and serum P-glycoprotein levels in epileptic patients: Associations with clinical features, seizure patterns, and drug resistance
1 Istanbul Medipol University, School of Medicine, Institute of Health Science, Department of Medical Pharmacology, Istanbul, Türkiye2 Istanbul Medipol University, Research Institute for Health Sciences and Technologies (SABITA), Istanbul, Türkiye
3 Umraniye Training and Research Hospital, Department of Neurology, Istanbul, Türkiye
4 Haydarpasa Numune Training and Research Hospital, Department of Neurology, Istanbul, Türkiye
5 Istanbul Medipol University, School of Medicine, Department of Medical Statistics and Medical Informatics, Istanbul, Türkiye
DOI : 10.23893/1307-2080.APS6348 Viewed : 2143 - Downloaded : 781 This study aimed to evaluate the association of serum HMGB-1 and serum P-gp levels with clinical characteristics, seizure patterns, and drug resistance in patients with epilepsy. Patients were divided into monotherapy (n=40) and polytherapy (n=40) groups, and their serum HMGB-1 and serum P-gp levels were analysed using the ELISA technique. In the multinomial logistic regression model, serum P-gp levels were significantly higher in the polytherapy group compared to the healthy control group (p=0.021). Additionally, to the best of our knowledge, this is the first study to analyse the correlation between serum HMGB-1 and serum P-gp levels. In this study, a moderate positive correlation was found between serum HMGB-1 and serum P-gp levels in the monotherapy group of epilepsy patients. Keywords : drug resistance, epilepsy, HMGB-1, P-glycoprotein, serum